Kathmere Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Kathmere Capital Management, LLC holds 7 biotech & pharma companies tracked by BioSniper, totaling $5.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$5.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 27,425 | $3.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 9,280 | $512K |
| SNYSanofi | 5,250 | $253K |
| PBYIPUMA BIOTECHNOLOGY, INC. | 29,779 | $190K |
| ARTLARTELO BIOSCIENCES, INC. | 13,250 | $100K |
| ORMPORAMED PHARMACEUTICALS INC. | 15,071 | $51K |
| BDTXBlack Diamond Therapeutics, Inc. | 13,813 | $29K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.